Your browser doesn't support javascript.
loading
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.
Viúdez, Antonio; Crespo, Guillermo; Gómez Dorronsoro, María Luisa; Arozarena, Imanol; Marín-Méndez, Juan Jesús; Custodio, Ana; Benavent, Marta; Goñi, Saioa; García-Paredes, Beatriz; Hernando, Jorge; Durantez, Maika; Alonso, Vicente; Riesco, María Del Carmen; López, Carlos; Jiménez-Fonseca, Paula; San Vicente, Borja López; González-Borja, Iranzu; Sevilla, Isabel; Hernández-Garcia, Irene; Carmona-Bayonas, Alberto; Capdevila, Jaume; Pérez-Sanz, Jairo; García-Carbonero, Rocío; Pérez-Ricarte, Leyre; Llanos, Marta; Vera, Ruth; De Jesús Acosta, Ana.
Afiliación
  • Viúdez A; Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), Institute for Health Research (Idisna), Pamplona, Spain; OncobionaTras Unit. Navarrabiomed, CHN, Universidad Pública de Navarra (UPNA), Idisna, Pamplona, Spain. Electronic address: antonioluis.viudez@iconplc.com.
  • Crespo G; Department of Medical Oncology, Hospital Universitario Burgos, Burgos, Spain.
  • Gómez Dorronsoro ML; Department of Pathology, Complejo Hospitalario de Navarra, Idisna, Pamplona, Spain.
  • Arozarena I; Cancer Signalling, Navarrabiomed, CHN, Idisna, Pamplona, Spain.
  • Marín-Méndez JJ; Datbow SL, Ansoáin, Spain.
  • Custodio A; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
  • Benavent M; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Goñi S; OncobionaTras Unit. Navarrabiomed, CHN, Universidad Pública de Navarra (UPNA), Idisna, Pamplona, Spain.
  • García-Paredes B; Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain.
  • Hernando J; Department of Medical Oncology, Hospital Universitario Vall D'Hebron, Barcelona, Spain.
  • Durantez M; Cancer Signalling, Navarrabiomed, CHN, Idisna, Pamplona, Spain.
  • Alonso V; Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Riesco MDC; Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • López C; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Jiménez-Fonseca P; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
  • San Vicente BL; Department of Medical Oncology, Hospital de Basurto, Bilbao, Spain.
  • González-Borja I; OncobionaTras Unit. Navarrabiomed, CHN, Universidad Pública de Navarra (UPNA), Idisna, Pamplona, Spain.
  • Sevilla I; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Hernández-Garcia I; Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), Institute for Health Research (Idisna), Pamplona, Spain.
  • Carmona-Bayonas A; Department of Medical Oncology, Hospital Universitario Morales Meseguer, UMU, IMI, Murcia, Spain.
  • Capdevila J; Department of Medical Oncology, Hospital Universitario Vall D'Hebron, Barcelona, Spain.
  • Pérez-Sanz J; OncobionaTras Unit. Navarrabiomed, CHN, Universidad Pública de Navarra (UPNA), Idisna, Pamplona, Spain.
  • García-Carbonero R; Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Pérez-Ricarte L; Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), Institute for Health Research (Idisna), Pamplona, Spain.
  • Llanos M; Department of Medical Oncology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Vera R; Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), Institute for Health Research (Idisna), Pamplona, Spain.
  • De Jesús Acosta A; Department of Medical Oncology, Johns Hopkins Hospital, Baltimore, USA.
Pancreatology ; 21(1): 215-223, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33358592
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Inmunohistoquímica / Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendocrinos / Everolimus / Inmunosupresores Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Inmunohistoquímica / Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendocrinos / Everolimus / Inmunosupresores Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Suiza